A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation

Alan N. Langnas, Wagner C. Marujo, Robert J. Stratta, R. Patrick Wood, Dinesh Ranjan, Claire Ozaki, Byers W. Shaw

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Splanchnic venous inflow is considered mandatory to ensure graft survival after liver transplantation. Over a 68-month period, we performed 570 liver transplants in 495 patients. Portal vein thrombosis was present in 16 patients. At transplant, the extent of the occlusion included portal vein alone (n = 4), portal including confluence of the splenic and superior mesenteric veins (n = 8), portal, splenic, and distal superior mesenteric veins (n = 2), and the entire portal vein, splenic vein, and superior mesenteric vein (n = 2). The operative approach included thrombectomy alone (n = 5), anastomosis at the confluence of the splenic and superior mesenteric splenic veins (n = 8), and extra-anatomic venous reconstruction (n = 3). The mean operative blood loss was 22 ± 22 units, and the mean operative time was 9.7 ± 4.8 hours. The 1-year actuarial survival rate was 81%, with a mean follow-up of 12.5 months. In summary, with a selective approach and the use of innovative forms of splanchnic venous inflow, portal vein thrombosis is no longer a contraindication to liver transplantation.

Original languageEnglish (US)
Pages (from-to)132-136
Number of pages5
JournalThe American Journal of Surgery
Volume163
Issue number1
DOIs
StatePublished - Jan 1992

Fingerprint

Mesenteric Veins
Portal Vein
Liver Transplantation
Thrombosis
Splenic Vein
Viscera
Transplants
Thrombectomy
Graft Survival
Operative Time
Survival Rate
Liver

ASJC Scopus subject areas

  • Surgery

Cite this

A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation. / Langnas, Alan N.; Marujo, Wagner C.; Stratta, Robert J.; Wood, R. Patrick; Ranjan, Dinesh; Ozaki, Claire; Shaw, Byers W.

In: The American Journal of Surgery, Vol. 163, No. 1, 01.1992, p. 132-136.

Research output: Contribution to journalArticle

Langnas, Alan N. ; Marujo, Wagner C. ; Stratta, Robert J. ; Wood, R. Patrick ; Ranjan, Dinesh ; Ozaki, Claire ; Shaw, Byers W. / A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation. In: The American Journal of Surgery. 1992 ; Vol. 163, No. 1. pp. 132-136.
@article{4a21027c8818445ead1a73ea1ada11fd,
title = "A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation",
abstract = "Splanchnic venous inflow is considered mandatory to ensure graft survival after liver transplantation. Over a 68-month period, we performed 570 liver transplants in 495 patients. Portal vein thrombosis was present in 16 patients. At transplant, the extent of the occlusion included portal vein alone (n = 4), portal including confluence of the splenic and superior mesenteric veins (n = 8), portal, splenic, and distal superior mesenteric veins (n = 2), and the entire portal vein, splenic vein, and superior mesenteric vein (n = 2). The operative approach included thrombectomy alone (n = 5), anastomosis at the confluence of the splenic and superior mesenteric splenic veins (n = 8), and extra-anatomic venous reconstruction (n = 3). The mean operative blood loss was 22 ± 22 units, and the mean operative time was 9.7 ± 4.8 hours. The 1-year actuarial survival rate was 81{\%}, with a mean follow-up of 12.5 months. In summary, with a selective approach and the use of innovative forms of splanchnic venous inflow, portal vein thrombosis is no longer a contraindication to liver transplantation.",
author = "Langnas, {Alan N.} and Marujo, {Wagner C.} and Stratta, {Robert J.} and Wood, {R. Patrick} and Dinesh Ranjan and Claire Ozaki and Shaw, {Byers W.}",
year = "1992",
month = "1",
doi = "10.1016/0002-9610(92)90265-S",
language = "English (US)",
volume = "163",
pages = "132--136",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation

AU - Langnas, Alan N.

AU - Marujo, Wagner C.

AU - Stratta, Robert J.

AU - Wood, R. Patrick

AU - Ranjan, Dinesh

AU - Ozaki, Claire

AU - Shaw, Byers W.

PY - 1992/1

Y1 - 1992/1

N2 - Splanchnic venous inflow is considered mandatory to ensure graft survival after liver transplantation. Over a 68-month period, we performed 570 liver transplants in 495 patients. Portal vein thrombosis was present in 16 patients. At transplant, the extent of the occlusion included portal vein alone (n = 4), portal including confluence of the splenic and superior mesenteric veins (n = 8), portal, splenic, and distal superior mesenteric veins (n = 2), and the entire portal vein, splenic vein, and superior mesenteric vein (n = 2). The operative approach included thrombectomy alone (n = 5), anastomosis at the confluence of the splenic and superior mesenteric splenic veins (n = 8), and extra-anatomic venous reconstruction (n = 3). The mean operative blood loss was 22 ± 22 units, and the mean operative time was 9.7 ± 4.8 hours. The 1-year actuarial survival rate was 81%, with a mean follow-up of 12.5 months. In summary, with a selective approach and the use of innovative forms of splanchnic venous inflow, portal vein thrombosis is no longer a contraindication to liver transplantation.

AB - Splanchnic venous inflow is considered mandatory to ensure graft survival after liver transplantation. Over a 68-month period, we performed 570 liver transplants in 495 patients. Portal vein thrombosis was present in 16 patients. At transplant, the extent of the occlusion included portal vein alone (n = 4), portal including confluence of the splenic and superior mesenteric veins (n = 8), portal, splenic, and distal superior mesenteric veins (n = 2), and the entire portal vein, splenic vein, and superior mesenteric vein (n = 2). The operative approach included thrombectomy alone (n = 5), anastomosis at the confluence of the splenic and superior mesenteric splenic veins (n = 8), and extra-anatomic venous reconstruction (n = 3). The mean operative blood loss was 22 ± 22 units, and the mean operative time was 9.7 ± 4.8 hours. The 1-year actuarial survival rate was 81%, with a mean follow-up of 12.5 months. In summary, with a selective approach and the use of innovative forms of splanchnic venous inflow, portal vein thrombosis is no longer a contraindication to liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0026537377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026537377&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(92)90265-S

DO - 10.1016/0002-9610(92)90265-S

M3 - Article

C2 - 1733361

AN - SCOPUS:0026537377

VL - 163

SP - 132

EP - 136

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 1

ER -